Navigation Links
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019 with GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck & Co & Tesaro Dominating

DUBLIN, Nov. 4, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019" report to their offering.

The analysts forecast the global chemotherapy induced nausea and vomiting drugs market to grow at a CAGR of 4.9% over the period 2014-2019.

Based on the type of CINV, different treatment regimens are prescribed. The classes of drugs used in the treatment of CINV are 5-HT3 receptor antagonists, NK1 receptor antagonists, corticosteroids, dopamine antagonists, benzodiazepines, and cannabinoids. Most of the drugs used in the treatment are helpful in the prevention of vomiting but show less effect in treating nausea.

The report, Global CINV Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global CINV drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

One major trend in the market is individuals tend to develop resistance to monotherapies over a period of time, resulting in the increased preference for combination therapies. These combination therapies have a better safety and efficacy profile, increasing their preference for treating CINV.

According to the report, one key driver of this market is patent expiries result in the loss of market exclusivity of a drug, leading to a rapid decline in its sales. This leads to the market entry of generic forms that have a similar efficacy and safety profile as the branded drug and are available at low prices. The patents of most of the CINV drugs have either expired or are set to expire by the end of the forecast period.

Further, the report states that one of the major challenges in the market is off-label drugs are unapproved medications, but show efficacy in the treatment of the condition. Many off-label drugs are used to manage CINV. Corticosteroids, such as dexamethasone, are commonly used to treat CINV.

Key vendors

  • GlaxoSmithKline
  • Helsinn
  • Heron Therapeutics
  • Merck & Co
  • Tesaro

Other prominent vendors

  • Acacia Pharma
  • Aphios
  • Barr Laboratories
  • Baxter Healthcare
  • Eisai
  • Especificos Stendhal
  • F.Hoffmann La Roche
  • Mundipharma
  • Mylan Pharmaceuticals
  • OPKO Health
  • Orchid Healthcare
  • Otsuka Pharmaceutical
  • ProStrakan
  • Sandoz (Novartis)
  • Solvay Pharmaceuticals
  • Specialised Therapeutics Australia
  • Sun Pharma
  • Taiho Pharmaceutical
  • Teva Pharmaceuticals

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Smart Pills Market 2015 Research Reports With 2021-24 Forecasts
2. Global Cardiovascular Partnering 2010-2015: Deal trends, players and financials - Reportlinker Review
3. Global Drug Delivery in Central Nervous System Diseases Report 2015-2019 & 2024
4. Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025
5. North America Leads Global Home Healthcare Market, but Asia Pacific not Far Behind: Transparency Market Research
6. Global Wearable Medical Device Market - Growth, Trends and Forecasts (2015-2020)
7. Anesthesia Monitoring Devices Market by Product, End User, and Geography - Global Forecast to 2020
8. Global Alpha Emitters Market - Growth, Trends and Forecasts (2015 - 2020)
9. Global Pharmaceutical Packaging Market 2015-2019 - Reportlinker Review
10. Cardiac Pacemaker Market 2020 Forecasts for Global and Regional Levels
11. Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylans Over-the-Counter Business
Post Your Comments:
(Date:10/10/2019)... , ... October 10, 2019 , ... ... Gala Cocktail Reception on Thursday, September 26, at the Westchester Country Club in ... the unwavering support of the organization and its mission. , “In Celebration” featured ...
(Date:10/8/2019)... (PRWEB) , ... October 09, 2019 , ... “When Seconds ... emotions, frustrations, and the realities of the HEMS world through telling the real stories ... Pilot” is the creation of published author Jay A. Humphrey, an EMS helicopter pilot. ...
(Date:10/8/2019)... ... October 08, 2019 , ... Respected dentist, Dr. Kenneth ... to enhance his skill and knowledge of dental implant diagnosis, placement and maintenance. ... four-part series of classes that combines in-depth lectures with hands-on workshops. Halfway through ...
Breaking Medicine Technology:
(Date:10/11/2019)... ... ... A Topping Out event was hosted today at the construction site of the Southwest ... event celebrated reaching the final height of the structure set to open in the ... in Texas, STA’s facility will be home to an organ recovery center including a ...
(Date:10/10/2019)... ... October 10, 2019 , ... Santa ... (IT) services for the healthcare industry, has completed the first phase of a ... the Commonwealth of The Bahamas towards a fully integrated health information management system ...
(Date:10/10/2019)... ... October 10, 2019 , ... In ... 21 was excited to hear the significant results of an independent study presented ... of Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline Malate ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... What unique ... and future state of aging and wellness in the nation? That question will be ... Active Aging Conference, Leadership Summit and Expo. The event will take place October 10-12, ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... majority interest in Advanced Fertility Care (AFC), an advanced reproductive services (RE) facility ... expand the availability of RE services to expectant families throughout Arizona and the ...
Breaking Medicine News(10 mins):